Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)

Overview of attention for article published in Open Access Journal of Clinical Trials, February 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 19 followers.

RT @AboutMyLupus: Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative…

24 Sep 2018

Reply Repost Favourite

Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial) https://t.co/2VmqXzJuKy https://t.co/PDKdw7Drwa